Abstract:Background: Depressive symptoms are common in patients with cancer and more prevalent in Chinese patients. The Center for Epidemiologic Studies Depression Scale is one of the most widely used self-report scales to assess depressive symptoms in both community and hospitalized samples. A revised Center for Epidemiologic Studies Depression Scale has been created, but the evidence on psychometric properties is limited. Objectives: To develop the Chinese version of the scale, and to examine the cross-cultural validity, structural validity, construct validity, internal consistency, test-retest reliability, measurement error, responsiveness, and floor/ceiling effect of the scale among patients with cancer according to the recommendation in the consensus-based standards for the selection of health status measurement instruments checklist. Design: A cross-sectional survey design with 33 participants (approximately 10%) completing the followup survey for evaluating the test-retest reliability. Settings: Randomly selected eight wards of an oncology hospital in China. Participants: Of the 595 patients we approached in the randomly selected eight wards, 310 gave their informed consent and completed the survey. Methods: The Chinese version of the Center for Epidemiologic Studies Depression Scale-Revised was developed by four researchers (two translators and two reviewers) who were proficient in both English and Chinese. Participants completed the scale and the depression module of the Patient Health Questionnaire. Principal components analyses, Spearman's correlation, the Mann-Whitney U test, Cronbach's alpha, and the intraclass correlation coefficient were used. Results: The cross-culture validity was excellent based on the consensus-based standards for the selection of the health status measurement instruments checklist. A two-factor structure was determined: somatic symptoms and affective-cognitive symptoms. The sufficient construct validity was supported by that the score of the Center for Epidemiologic Studies Depression Scale-Revised was strongly correlated with the depression module of the Patient Health Questionnaire score (rho = 0.73, p < 0.001) and patients who had received chemotherapy (p = 0.002 )/radiotherapy (p = 0.035) reported higher scores of depression than those who have not. The Cronbach's alphas of the total scale and subscales ranged from 0.82-0.88. The test-retest reliability was sufficient (intraclass correlation coefficient = 0.73-0.81, all p < 0.001) for total scale and subscales. The smallest detectable change was 2.98 and the responsiveness was adequate, with no floor/ceiling effect. Conclusions: This study supports the Chinese version of the Center for Epidemiologic Studies Depression Scale-Revised as a valid and reliable measurement of depressive symptoms in patients with cancer. (C) 2019 Elsevier Ltd. All rights reserved.

Translation and Validation of the Chinese Version of the BCPT Eight Symptom Scale (BESS) in Breast Cancer Patients

Translation, Validity, and Reliability of the Chinese Version of the Breast Cancer Survivor Self-efficacy Scale in China.

Psychometric properties of the Breast Cancer and Lymphedema Symptom Experience Index: The Chinese version

Psychometric properties of the Breast Cancer Awareness Measurement among Chinese women: a cross-sectional study

Psychometric Evaluation of the Chinese Version of the Vulvovaginal Symptom Questionnaire in Women With Breast Cancer

Evaluation of the Psychometric Properties of the Translated Physical Self-Perception Profile Among Chinese Breast Cancer Survivor

Psychometric properties of the Chinese version of the Courtauld Emotional Control Scale in women newly diagnosed with breast cancer

Psychometric Properties of the Chinese Version of the Center for Epidemiologic Studies Depression Scale-Revised in Patients with Cancer: A Cross-Sectional Study.

Development of the body image self-rating questionnaire for breast cancer (BISQ-BC) for Chinese mainland patients

Development and validation of the NCC-BC-A scale to assess patient-reported outcomes for breast cancer patients in China

Assessment of the psychometric properties of the traditional Chinese version of the cancer survivors' self-efficacy scale

Validity and reliability of the Chinese version of the Patient-Reported Outcomes Measurement Information System adult profile-57 (PROMIS-57)

Reliability and Validity of the Translated Chinese Version of Comprehensive Assessment of Acceptance and Commitment Therapy Processes (Compact-C) in Breast Cancer Survivors

Validation of the Chinese version bodily distress syndrome checklist in Chinese out-patients of general hospitals

Psychometric Properties of the Chinese Version of Female Self-Advocacy in Cancer Survivorship (FSACS-C) Scale

Reliability and Validity of the Benefit Finding Scale in Women with Breast Cancer

Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients

Translation and Evaluation of Chinese Version of the Symptom Experience Index.

Translation and validation of the Chinese version of Palliative Care Self-Efficacy Scale

Reliability and validity of the Chinese version of the Benefit Finding Questionnaire for people with mental disorders

Psychometric Properties of the Chinese Version of Female Self-Advocacy in Cancer Survivorship Scale